Rb-82 “ARMI” Trial  –   Completed

Rubidium-82 – An Alternative Radiopharmaceutical for Myocardial Imaging (Rb-ARMI)



In 2014 Canadian Rubidium-82 PET imaging sites transitioned from the Rb-ARMI clinical trial to the REST-PET (Rubidium Elution System Testing) device trial.

There were five clinical sites in Canada registered under the REST-PET trial: the University of Ottawa Heart Institute (Ottawa, ON) is the study sponsor and coordinating centre / St. Joseph’s Healthcare (Hamilton, ON) / KMH Cardiology (Toronto, ON) / University of Alberta Hospital (Edmonton, AB) and Institut Universitaire de Cardiologie et Pneumologie de Québec (Québec, QC).

For more information on the ARMI Trial, please visit:  www.clinicaltrials.gov/ct2/show/NCT01128023